Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kannalife Sciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Kannalife Sciences

Kannalife Sciences

Seed

KannaLife Sciences Inc. develops natural phyto-medical products and therapeutic agents for health, wellness, and various ailments.

HQ
Doylestown, PA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded in 2010 by Dean Petkanas and Thoma Kikis, Kannalife Sciences Inc. is a biopharmaceutical company headquartered in Doylestown, Pennsylvania. As a subsidiary of Neuropathix, Inc., Kannalife focuses on developing natural phyto-medical products and next-generation therapeutics targeting inflammation and neurotoxicity. The company holds an exclusive license for the commercialization of the U.S. patent "Cannabinoids as Antioxidants and Neuroprotectants," granted by NIH-OTT, and aims to address significant unmet medical needs through its innovative pipeline.

Notable figures associated with Kannalife include Dr. Tage Honoré, Chairman of the Board of Advisors, and Terrence O. Tormey. The company has achieved significant milestones, such as bolstering its intellectual property portfolio with multiple patents in key European territories. Kannalife's work has had a considerable impact on the pharmaceutical industry, particularly in the realm of cannabinoid-based therapeutics, positioning it as a leader in addressing oxidative and neuro-toxic stresses from various ailments.

Kannalife Sciences - Similar Companies

Neuropathix logo

Neuropathix

neuropathix.com

Panacea Life Sciences Holdings logo

Panacea Life Sciences Holdings

panacealife.com

Pono Life Sciences logo

Pono Life Sciences

Wellcana logo

Wellcana

Ananda Scientific logo

Ananda Scientific

Receptor Life Sciences logo

Receptor Life Sciences

receptorlife.com

CNBX Pharmaceuticals logo

CNBX Pharmaceuticals

cnbxpharma.com

Canaria Therapeutics logo

Canaria Therapeutics

Animal Life Sciences logo

Animal Life Sciences

Applied Biosciences logo

Applied Biosciences

Kadmus Pharmaceuticals logo

Kadmus Pharmaceuticals

Nerx Biosciences logo

Nerx Biosciences

Hennepin Life Sciences logo

Hennepin Life Sciences

Emerald Health Pharmaceuticals logo

Emerald Health Pharmaceuticals

Kezar Life Sciences logo

Kezar Life Sciences

Kannalife Sciences - Quick Facts

Who are Kannalife Sciences' competitors?

Companies similar to Kannalife Sciences include Neuropathix, Panacea Life Sciences Holdings, Pono Life Sciences and Wellcana.

When was Kannalife Sciences founded?

Kannalife Sciences was founded in 2010.

Where is Kannalife Sciences' headquarters located?

Kannalife Sciences' headquarters is located in Doylestown, PA, US.

When was Kannalife Sciences' last funding round?

Kannalife Sciences' most recent funding round was for $3M (USD) in September 2021.

How much has Kannalife Sciences raised to-date?

As of Sep 28, 2021, Kannalife Sciences has raised a total of $4.5M (USD).

How many employees does Kannalife Sciences have?

Kannalife Sciences has 5 employees as of Feb 5, 2024.

Kannalife Sciences - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research